Log in to save to my catalogue

Fragile Histidine Triad Gene Inactivation in Lung Cancer: The European Early Lung Cancer Project

Fragile Histidine Triad Gene Inactivation in Lung Cancer: The European Early Lung Cancer Project

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_hal_primary_oai_HAL_inserm_00359752v1

Fragile Histidine Triad Gene Inactivation in Lung Cancer: The European Early Lung Cancer Project

About this item

Full title

Fragile Histidine Triad Gene Inactivation in Lung Cancer: The European Early Lung Cancer Project

Publisher

New York, NY: Am Thoracic Soc

Journal title

American journal of respiratory and critical care medicine, 2009-03, Vol.179 (5), p.396-401

Language

English

Formats

Publication information

Publisher

New York, NY: Am Thoracic Soc

More information

Scope and Contents

Contents

Fragile histidine triad (FHIT) is a tumor suppressor gene involved in the pathogenesis of lung cancer.
The purpose of this study was to investigate the different molecular alterations leading to the inactivation of FHIT gene function and to validate their use as biomarkers of risk for progression of the disease in patients belonging to the multi...

Alternative Titles

Full title

Fragile Histidine Triad Gene Inactivation in Lung Cancer: The European Early Lung Cancer Project

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_hal_primary_oai_HAL_inserm_00359752v1

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_hal_primary_oai_HAL_inserm_00359752v1

Other Identifiers

ISSN

1073-449X

E-ISSN

1535-4970

DOI

10.1164/rccm.200807-1153OC